Microbiology Testing Market

The market for microbiological testing is expanding as manufacturers and industrial settings increasingly emphasize product safety, contamination control, and regulatory compliance. Accurate and timely microbiological analysis is increasingly necessary as production volumes in pharmaceuticals, biotechnology, food, water, and environmental monitoring rise. Technological advances in testing are increasing the speed, sensitivity, and reliability of detection, creating many opportunities as quick, automated solutions become more widely used. However, the high cost of sophisticated systems and the inconsistent quality of results from low-cost suppliers remain major obstacles. Despite these limitations, the industry-wide emphasis on quality assurance, process validation, and risk reduction supports the growing demand for dependable, high-quality microbial testing.

Major companies in this market include Merck KGaA (Germany), bioMérieux (France), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), and Neogen Corporation (US). These companies focus on increasing sales, launching new products, and obtaining product approvals. These organic and inorganic strategies have allowed the market players to expand across geographies by offering microbiology testing products.

To know about the assumptions considered for the study download the pdf brochure

In February 2025, bioMérieux launched GENE-UP TYPER, an innovative diagnostic solution for the food industry that rapidly analyzes the root cause of Listeria monocytogenes contamination.

In June 2023, Becton, Dickinson and Company opened a new USD 4.69 million (€4 million) research and development facility in Blackrock, Dublin, and announced an additional USD 35.18million (€30 million) investment to expand its manufacturing facility in Enniscorthy, Wexford.

bioMérieux (France)

bioMérieux has a strong presence in the microbiology testing market, sustained by its diverse product offerings and global distribution network. The company offers solutions in immunoassays, molecular diagnostics, and microbiology systems. Its presence is further strengthened by operations in more than 45 countries and distribution in over 160 markets, enabling it to cater to diverse healthcare needs worldwide. In addition, bioMérieux has partnerships with healthcare institutions, governments, and research institutions, which help it adapt to changing diagnostic needs in developed and emerging markets.

Becton, Dickinson and Company (US)

Becton, Dickinson and Company is a leader in the microbiology testing market, backed by a strong product portfolio and a history of laboratory diagnostics. The company provides a broad range of solutions in culture media, sample collection, identification, and automated microbiology systems for quality control and testing. The company’s manufacturing and distribution infrastructure enables it to reach a wide market base in North America, Europe, Asia, and other geographies. BD’s ongoing investments in product innovation, automation, and efficiency, along with its strong relationships with laboratories and the industry, help the company meet the evolving testing demands in established and emerging markets.

Market Ranking

The microbiology testing market is consolidated, with the top five players accounting for 35-40% of the market share in 2025. The market is dominated by the top five players, including Merck KGaA (Germany), bioMérieux (France), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), and Neogen Corporation (US). They have strong product portfolios and robust R&D capabilities, enabling them to provide efficient microbiology testing products. bioMérieux (France) has gained its market position through strategic partnerships. Thermo Fisher Scientific Inc. (US) has strengthened its position with its worldwide reach. Becton, Dickinson and Company (US) has expanded its market presence by increasing its facility footprint. In February 2025, Merck’s Life Science business entered into a global distribution and collaboration agreement with Rapid Micro Biosystems, expanding worldwide access to the Growth Direct platform. The partnership broadens Merck’s global sales channels and creates opportunities for collaboration across supply chain efficiencies, service offerings, and joint product development.

Related Reports:

"Microbiology Testing Market by Product [Instrument, Reagent & Kit, Consumable], Technology [Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)], End User [Pharma, Biotech, Food, Water, Environmental Testing]-Global Forecast to 2031" 

Contact:

Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com